1262947

Alexion Pharmaceuticals, Inc. — FEI 3014801948

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System